Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Wołomin

16 clinical trials in Wołomin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Wołomin at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

16 trials in Wołomin

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cytisine
  • Sponsor:University of Rzeszow
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Namodenoson
  • Sponsor:Can-Fite Biopharma Ltd.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:SACCHAROMYCES CEREVISIAE TYPE D EXTRACT
  • Sponsor:Laboratoires Grimberg
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriatic arthropathy

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Wołomin

What the registry says about research in the country

01 Autoimmune Conditions

Multiple studies focusing on Sjögren's Disease treatments, investigating novel therapies including sibeprenlimab, dazodalibep, and efgartigimod. Research aims to evaluate systemic disease activity and improve treatment outcomes.

  • Primary Sjögren's Syndrome
  • Systemic Disease Activity
  • Novel Therapeutic Approaches

Comprehensive evaluation of long-term safety and efficacy in treating systemic manifestations.

02 Rheumatology Research

Advancing treatments for Psoriatic Arthritis and Axial Spondyloarthritis, with studies examining multiple therapeutic agents including sonelokimab, deucravacitinib, and tofacitinib.

  • Biologic DMARD Studies
  • Disease Remission Assessment
  • Treatment Response Evaluation

Focus on both treatment-naïve patients and those with inadequate response to previous therapies.

03 Respiratory & Allergy Studies

Research encompassing influenza treatment and allergic conditions, including investigations of baloxavir marboxil and innovative treatments for birch pollen allergies.

  • Viral Resistance Patterns
  • Allergic Rhinitis Management
  • Therapeutic Response Assessment

Studies include both therapeutic and preventive approaches for respiratory conditions.

04 Additional Clinical Areas

Diverse research portfolio including studies on electronic cigarette cessation and chronic kidney disease-associated conditions.

  • Smoking Cessation Therapies
  • Renal Disease Complications
  • Quality of Life Improvements

Investigating novel approaches to address modern health challenges and chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.